Young TB, Rimm EB, D'Alessio DJ: Cross-sectional study of recurrent herpes labialis. Prevalence and risk factors. American journal of epidemiology 1988, 127(3):612-625.
Armstrong GL, Schillinger J, Markowitz L, Nahmias AJ, Johnson RE, McQuillan GM, St Louis ME: Incidence of herpes simplex virus type 2 infection in the United States. American journal of epidemiology 2001, 153(9):912-920.
Obara Y, Furuta Y, Takasu T, Suzuki S, Suzuki H, Matsukawa S, Fujioka Y, Takahashi H, Kurata T, Nagashima K: Distribution of herpes simplex virus types 1 and 2 genomes in human spinal ganglia studied by PCR and in situ hybridization. Journal of medical virology 1997, 52(2):136-142.
Looker KJ, Magaret AS, May MT, Turner KM, Vickerman P, Gottlieb SL, Newman LM: Global and Regional Estimates of Prevalent and Incident Herpes Simplex Virus Type 1 Infections in 2012. PloS one 2015, 10(10):e0140765.
Looker KJ, Magaret AS, Turner KM, Vickerman P, Gottlieb SL, Newman LM: Global estimates of prevalent and incident herpes simplex virus type 2 infections in 2012. PloS one 2015, 10(1):e114989.
Carr DJJ, Härle P, Gebhardt BM: The Immune Response to Ocular Herpes Simplex Virus Type 1 Infection. Experimental Biology and Medicine 2001, 226(5):353-366.
Edell AR, Cohen EJ: Herpes simplex and herpes zoster eye disease: presentation and management at a city hospital for the underserved in the United States. Eye & contact lens 2013, 39(4):311-314.
Koizumi N, Suzuki T, Uno T, Chihara H, Shiraishi A, Hara Y, Inatomi T, Sotozono C, Kawasaki S, Yamasaki K et al: Cytomegalovirus as an etiologic factor in corneal endotheliitis. Ophthalmology 2008, 115(2):292-297.e293.
Inoue T, Takamatsu F, Kubota A, Hori Y, Maeda N, Nishida K: Human herpesvirus 8 in corneal endotheliitis resulting in graft failure after penetrating keratoplasty refractory to allograft rejection therapy. Archives of ophthalmology (Chicago, Ill: 1960) 2011, 129(12):1629-1630.
Dawson CR, Togni B: Herpes simplex eye infections: clinical manifestations, pathogenesis and management. Survey of ophthalmology 1976, 21(2):121-135.
Liesegang TJ: Epidemiology of ocular herpes simplex. Natural history in Rochester, Minn, 1950 through 1982. Archives of ophthalmology (Chicago, Ill: 1960) 1989, 107(8):1160-1165.
Liesegang TJ, Melton LJ, 3rd, Daly PJ, Ilstrup DM: Epidemiology of ocular herpes simplex. Incidence in Rochester, Minn, 1950 through 1982. Archives of ophthalmology (Chicago, Ill: 1960) 1989, 107(8):1155-1159.
Darougar S, Wishart MS, Viswalingam ND: Epidemiological and clinical features of primary herpes simplex virus ocular infection. The British journal of ophthalmology 1985, 69(1):2-6.
Young RC, Hodge DO, Liesegang TJ, Baratz KH: Incidence, recurrence, and outcomes of herpes simplex virus eye disease in Olmsted County, Minnesota, 1976-2007: the effect of oral antiviral prophylaxis. Archives of ophthalmology (Chicago, Ill: 1960) 2010, 128(9):1178-1183.
Holland EJ, Schwartz GS: Classification of herpes simplex virus keratitis. Cornea 1999, 18(2):144-154.
Polcicova K, Biswas PS, Banerjee K, Wisner TW, Rouse BT, Johnson DC: Herpes keratitis in the absence of anterograde transport of virus from sensory ganglia to the cornea. Proceedings of the National Academy of Sciences of the United States of America 2005, 102(32):11462-11467.
Park PJ, Chang M, Garg N, Zhu J, Chang JH, Shukla D: Corneal lymphangiogenesis in herpetic stromal keratitis. Survey of ophthalmology 2015, 60(1):60-71.
Kaye S, Choudhary A: Herpes simplex keratitis. Progress in retinal and eye research 2006, 25(4):355-380.
O'Brien WJ, Palmer ML, Guy J, Taylor JL: Endothelial barrier function and Na+/K(+)-ATPase pump density in herpetic stromal disease. Investigative ophthalmology & visual science 1996, 37(1):29-36.
Chucair-Elliott AJ, Zheng M, Carr DJ: Degeneration and regeneration of corneal nerves in response to HSV-1 infection. Investigative ophthalmology & visual science 2015, 56(2):1097-1107.
Nagasato D, Araki-Sasaki K, Kojima T, Ideta R, Dogru M: Morphological changes of corneal subepithelial nerve plexus in different types of herpetic keratitis. Japanese journal of ophthalmology 2011, 55(5):444-450.
Liesegang TJ: Ocular herpes simplex infection: pathogenesis and current therapy. Mayo Clinic proceedings 1988, 63(11):1092-1105.
Hughes WF: Treatment of herpes simplex keratitis. A review. American journal of ophthalmology 1969, 67(3):313-328.
Fulhorst HW, Richards AB, Bowbyes J, Jones BR: Cryotherapy of epithelial herpes simplex keratitis. American journal of ophthalmology 1972, 73(1):46-51.
Austin DJ, Walker WM: Idoxuridine and iodization in the treatment of simple dendritic ulceration. Transactions of the ophthalmological societies of the United Kingdom 1974, 94(2):553.
Davidson SI, Evans PJ: IDU AND THE TREATMENT OF HERPES SIMPLEX KERATITIS. The British journal of ophthalmology 1964, 48:678-683.
Wilhelmus KR: Interventions for herpes simplex virus epithelial keratitis. The Cochrane database of systematic reviews 2003(3):Cd002898.
Coster DJ, Jones BR, Falcon MG: Role of debridement in the treatment of herpetic keratitis. Transactions of the ophthalmological societies of the United Kingdom 1977, 97(2):314-317.
Jones BR, Coster DJ, Fison PN, Thompson GM, Cobo LM, Falcon MG: Efficacy of acycloguanosine (Wellcome 248U) against herpes-simplex corneal ulcers. Lancet (London, England) 1979, 1(8110):243-244.
Parlato CJ, Cohen EJ, Sakauye CM, Dreizen NG, Galentine PG, Laibson PR: Role of debridement and trifluridine (trifluorothymidine) in herpes simplex dendritic keratitis. Archives of ophthalmology (Chicago, Ill: 1960) 1985, 103(5):673-675.
Jensen KB, Nissen SH, Jessen F: Acyclovir in the treatment of herpetic keratitis. Acta ophthalmologica 1982, 60(4):557-563.
Hung SO, Patterson A, Clark DI, Rees PJ: Oral acyclovir in the management of dendritic herpetic corneal ulceration. The British journal of ophthalmology 1984, 68(6):398-400.
Herbort CP, Buechi ER, Matter M: Blunt spatula debridement and trifluorothymidine in epithelial herpetic keratitis. Current eye research 1987, 6(1):225-229.
Wilhelmus KR, Coster DJ, Jones BR: Acyclovir and debridement in the treatment of ulcerative herpetic keratitis. American journal of ophthalmology 1981, 91(3):323-327.
Kaufman HE: Clinical cure of herpes simplex keratitis by 5-iodo-2-deoxyuridine. Proceedings of the Society for Experimental Biology and Medicine Society for Experimental Biology and Medicine (New York, NY) 1962, 109:251-252.
Chen CW: [Adverse side effects caused by topically applied antiviral agents in herpetic keratitis]. Gaoxiong yi xue ke xue za zhi = The Kaohsiung journal of medical sciences 1989, 5(8):416-429.
Amon RB, Lis AW, Hanifin JM: Allergic contact dermatitis caused by idoxuridine. Patterns of cross reactivity with other pyrimidine analogues. Archives of dermatology 1975, 111(12):1581-1584.
Balderson DE, Cai G, Fries MA, Kleinman DM, McLaughlin MM, Trivedi TM, Wurzelmann JI, Young SB: A systematic review and meta-analysis to compare the efficacy of acyclovir 3% ophthalmic ointment to idoxuridine in curing herpetic keratitis by Day 7 of treatment. BMC ophthalmology 2015, 15:42.
Wilhelmus KR: Antiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratitis. The Cochrane database of systematic reviews 2015, 1:Cd002898.
Whitley R, Alford C, Hess F, Buchanan R: Vidarabine: a preliminary review of its pharmacological properties and therapeutic use. Drugs 1980, 20(4):267-282.
Elion GB, Furman PA, Fyfe JA, de Miranda P, Beauchamp L, Schaeffer HJ: Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl) guanine. Proceedings of the National Academy of Sciences of the United States of America 1977, 74(12):5716-5720.
Richards DM, Carmine AA, Brogden RN, Heel RC, Speight TM, Avery GS: Acyclovir. A review of its pharmacodynamic properties and therapeutic efficacy. Drugs 1983, 26(5):378-438.
McCulley JP, Binder PS, Kaufman HE, O'Day DM, Poirier RH: A double-blind, multicenter clinical trial of acyclovir vs idoxuridine for treatment of epithelial herpes simplex keratitis. Ophthalmology 1982, 89(10):1195-1200.
Hovding G: A comparison between acyclovir and trifluorothymidine ophthalmic ointment in the treatment of epithelial dendritic keratitis. A double blind, randomized parallel group trial. Acta ophthalmologica 1989, 67(1):51-54.
Sahin A, Hamrah P: Acute Herpetic Keratitis: What is the Role for Ganciclovir Ophthalmic Gel? Ophthalmology and eye diseases 2012, 4:23-34.
Colin J, Hoh HB, Easty DL, Herbort CP, Resnikoff S, Rigal D, Romdane K: Ganciclovir ophthalmic gel (Virgan; 0.15%) in the treatment of herpes simplex keratitis. Cornea 1997, 16(4):393-399.
Chou TY, Hong BY: Ganciclovir ophthalmic gel 0.15% for the treatment of acute herpetic keratitis: background, effectiveness, tolerability, safety, and future applications. Therapeutics and clinical risk management 2014, 10:665-681.
Kaufman HE, Haw WH: Ganciclovir ophthalmic gel 0.15%: safety and efficacy of a new treatment for herpes simplex keratitis. Current eye research 2012, 37(7):654-660.
Hoh HB, Hurley C, Claoue C, Viswalingham M, Easty DL, Goldschmidt P, Collum LM: Randomised trial of ganciclovir and acyclovir in the treatment of herpes simplex dendritic keratitis: a multicentre study. The British journal of ophthalmology 1996, 80(2):140-143.
Collum Lm Fau - Logan P, Logan P Fau - McAuliffe-Curtin D, McAuliffe-Curtin D Fau - Hung SO, Hung So Fau - Patterson A, Patterson A Fau - Rees PJ, Rees PJ: Randomised double-blind trial of acyclovir (Zovirax) and adenine arabinoside in herpes simplex amoeboid corneal ulceration. (0007-1161 (Print)).
Wilhelmus KR, Gee L, Hauck WW, Kurinij N, Dawson CR, Jones DB, Barron BA, Kaufman HE, Sugar J, Hyndiuk RA et al: Herpetic Eye Disease Study. A controlled trial of topical corticosteroids for herpes simplex stromal keratitis. Ophthalmology 1994, 101(12):1883-1895; discussion 1895-1886.
Barron BA, Gee L, Hauck WW, Kurinij N, Dawson CR, Jones DB, Wilhelmus KR, Kaufman HE, Sugar J, Hyndiuk RA et al: Herpetic Eye Disease Study. A controlled trial of oral acyclovir for herpes simplex stromal keratitis. Ophthalmology 1994, 101(12):1871-1882.
Collum LM, Grant DM: A double-blind comparative trial of acyclovir and adenine arabinoside in combination with dilute betamethasone in the management of herpetic disciform keratitis. Current eye research 1987, 6(1):221-224.
Colin J, Chastel C, Kaufman HE, Kissling GE: Combination therapy for dendritic keratitis with acyclovir and vidarabine. Journal of ocular pharmacology 1987, 3(1):39-42.
Sanitato JJ, Asbell PA, Varnell ED, Kissling GE, Kaufman HE: Acyclovir in the treatment of herpetic stromal disease. American journal of ophthalmology 1984, 98(5):537-547.
Beutner KR: Valacyclovir: a review of its antiviral activity, pharmacokinetic properties, and clinical efficacy. Antiviral research 1995, 28(4):281-290.
Tyring SK, Douglas JM, Jr., Corey L, Spruance SL, Esmann J: A randomized, placebo-controlled comparison of oral valacyclovir and acyclovir in immunocompetent patients with recurrent genital herpes infections. The Valaciclovir International Study Group. Archives of dermatology 1998, 134(2):185- 191.
Schuster AK, Harder BC, Schlichtenbrede FC, Jarczok MN, Tesarz J: Valacyclovir versus acyclovir for the treatment of herpes zoster ophthalmicus in immunocompetent patients. The Cochrane database of systematic reviews 2016, 11:Cd011503.
Colin J, Prisant O, Cochener B, Lescale O, Rolland B, Hoang-Xuan T: Comparison of the efficacy and safety of valaciclovir and acyclovir for the treatment of herpes zoster ophthalmicus. Ophthalmology 2000, 107(8):1507- 1511.
Miserocchi E, Modorati G, Galli L, Rama P: Efficacy of valacyclovir vs acyclovir for the prevention of recurrent herpes simplex virus eye disease: a pilot study. American journal of ophthalmology 2007, 144(4):547-551.
Goldblum D, Bachmann C, Tappeiner C, Garweg J, Frueh BE: Comparison of oral antiviral therapy with valacyclovir or acyclovir after penetrating keratoplasty for herpetic keratitis. The British journal of ophthalmology 2008, 92(9):1201-1205.
Sozen E, Avunduk AM, Akyol N: Comparison of efficacy of oral valacyclovir and topical acyclovir in the treatment of herpes simplex keratitis: a randomized clinical trial. Chemotherapy 2006, 52(1):29-31.
Pavan-Langston D, Nelson DJ: Intraocular penetration of trifluridine. American journal of ophthalmology 1979, 87(6):814-818.
Poirier RH, Kingham JD, de Miranda P, Annel M: Intraocular antiviral penetration. Archives of ophthalmology (Chicago, Ill: 1960) 1982, 100(12):1964- 1967.
Castela N, Vermerie N, Chast F, Sauvageon-Martre H, Denis J, Godard V, Goldschmidt P, Pouliquen Y: Ganciclovir ophthalmic gel in herpes simplex virus rabbit keratitis: intraocular penetration and efficacy. Journal of ocular pharmacology 1994, 10(2):439-451.
Wang X, Wang L, Wu N, Ma X, Xu J: Clinical efficacy of oral ganciclovir for prophylaxis and treatment of recurrent herpes simplex keratitis. Chinese medical journal 2015, 128(1):46-50.
Ar MC, Ozbalak M, Tuzuner N, Bekoz H, Ozer O, Ugurlu K, Tabak F, Ferhanoglu B: Severe bone marrow failure due to valganciclovir overdose after renal transplantation from cadaveric donors: four consecutive cases. Transplantation proceedings 2009, 41(5):1648-1653.
Tomonari A, Iseki T, Takahashi S, Ooi J, Yamada T, Takasugi K, Nagamura F, Uchimaru K, Tojo A, Asano S: Ganciclovir-related neutropenia after preemptive therapy for cytomegalovirus infection: comparison between cord blood and bone marrow transplantation. Annals of hematology 2004, 83(9):573-577.
Wilhelmus KR, Dawson CR, Barron BA, Bacchetti P, Gee L, Jones DB, Kaufman HE, Sugar J, Hyndiuk RA, Laibson PR et al: Risk factors for herpes simplex virus epithelial keratitis recurring during treatment of stromal keratitis or iridocyclitis. Herpetic Eye Disease Study Group. The British journal of ophthalmology 1996, 80(11):969-972.
Oral acyclovir for herpes simplex virus eye disease: effect on prevention of epithelial keratitis and stromal keratitis. Herpetic Eye Disease Study Group. Archives of ophthalmology (Chicago, Ill: 1960) 2000, 118(8):1030-1036.
Ma JX, Wang LN, Zhou RX, Yu Y, Du TX: Real-time polymerase chain reaction for the diagnosis of necrotizing herpes stromal keratitis. International journal of ophthalmology 2016, 9(5):682-686.
Fukuda M, Deai T, Hibino T, Higaki S, Hayashi K, Shimomura Y: Quantitative analysis of herpes simplex virus genome in tears from patients with herpetic keratitis. Cornea 2003, 22(7 Suppl):S55-60.
Dutt S, Acharya M, Gour A, Sapra N, Chauhan L, Mathur U: Clinical efficacy of oral and topical acyclovir in herpes simplex virus stromal necrotizing keratitis. Indian journal of ophthalmology 2016, 64(4):292-295.
Knickelbein JE, Hendricks RL, Charukamnoetkanok P: Management of herpes simplex virus stromal keratitis: an evidence-based review. Survey of ophthalmology 2009, 54(2):226-234.
Bauer D, Wasmuth S, Hermans P, Hennig M, Meller K, Meller D, van Rooijen N, Tseng SC, Steuhl KP, Heiligenhaus A: On the influence of neutrophils in corneas with necrotizing HSV-1 keratitis following amniotic membrane transplantation. Experimental eye research 2007, 85(3):335-345.
Yang YN, Bauer D, Wasmuth S, Steuhl KP, Heiligenhaus A: Matrix metalloproteinases (MMP-2 and 9) and tissue inhibitors of matrix metalloproteinases (TIMP-1 and 2) during the course of experimental necrotizing herpetic keratitis. Experimental eye research 2003, 77(2):227-237.
van Ganswijk R, Oosterhuis JA, Swart-van den Berg M, Versteeg J: Acyclovir treatment in stromal herpetic keratitis. Documenta ophthalmologica Advances in ophthalmology 1983, 55(1-2):57-61.
Heiligenhaus A, Bauer D, Meller D, Steuhl KP, Tseng SC: Improvement of HSV-1 necrotizing keratitis with amniotic membrane transplantation. Investigative ophthalmology & visual science 2001, 42(9):1969-1974.
Spira C, Szentmary N, Hasenfus A, Sauter M, Smola S, Seitz B: [Therapy refractory stromal Herpes keratitis under aciclovir]. Der Ophthalmologe: Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 2014, 111(7):654-659.
Shi W, Chen M, Xie L: Amniotic membrane transplantation combined with antiviral and steroid therapy for herpes necrotizing stromal keratitis. Ophthalmology 2007, 114(8):1476-1481.
Heiligenhaus A, Li H, Hernandez Galindo EE, Koch JM, Steuhl KP, Meller D: Management of acute ulcerative and necrotising herpes simplex and zoster keratitis with amniotic membrane transplantation. The British journal of ophthalmology 2003, 87(10):1215-1219.
Gao H, Jia Y, Li S, Wang T, Tan Y, Shi W: Conjunctival flap covering combined with antiviral and steroid therapy for severe herpes simplex virus necrotizing stromal keratitis. The Scientific World Journal 2015, 2015:565964.
Lesher MP, Lohman LE, Yeakley W, Lass J: Recurrence of herpetic stromal keratitis after a conjunctival flap surgical procedure. American journal of ophthalmology 1992, 114(2):231-233.
Wang J, Zhao G, Xie L, Chen M, Zhao J: Therapeutic effect of deep anterior lamellar keratoplasty for active or quiescent herpetic stromal keratitis. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 2012, 250(8):1187-1194.
Hillenaar T, Weenen C, Wubbels RJ, Remeijer L: Endothelial involvement in herpes simplex virus keratitis: an in vivo confocal microscopy study. Ophthalmology 2009, 116(11):2077-2086.e2071-2072.
Amano S, Oshika T, Kaji Y, Numaga J, Matsubara M, Araie M: Herpes simplex virus in the trabeculum of an eye with corneal endotheliitis. American journal of ophthalmology 1999, 127(6):721-722.
Kasetsuwan N, Tangmonkongvoragul C: Concomitant herpes simplex virus and cytomegalovirus endotheliitis in immunocompetent patient. BMJ case reports 2013, 2013.
Sugioka K, Drake JD, Fukuda M, Shimomura Y, Hwang DG: Susceptibility of human corneal endothelial cells to HSV-1 infection. Current eye research 2005, 30(10):863-869.
Collum LM, Logan P, Ravenscroft T: Acyclovir (Zovirax) in herpetic disciform keratitis. The British journal of ophthalmology 1983, 67(2):115-118.
Porter SM, Patterson A, Kho P: A comparison of local and systemic acyclovir in the management of herpetic disciform keratitis. The British journal of ophthalmology 1990, 74(5):283-285.
Collum LM, O'Connor M, Logan P: Comparison of the efficacy and toxicity of acyclovir and of adenine arabinoside when combined with dilute betamethasone in herpetic disciform keratitis: preliminary results of a doubleblind trial. Transactions of the ophthalmological societies of the United Kingdom 1983, 103 (Pt 6):597-599.
Power WJ, Hillery MP, Benedict-Smith A, Collum LM: Acyclovir ointment plus topical betamethasone or placebo in first episode disciform keratitis. The British journal of ophthalmology 1992, 76(12):711-713.
Hsu HY, Modi D: Etiologies, Quantitative Hypoesthesia, and Clinical Outcomes of Neurotrophic Keratopathy. Eye & contact lens 2015, 41(5):314- 317.
Sacchetti M, Lambiase A: Diagnosis and management of neurotrophic keratitis. Clinical ophthalmology (Auckland, NZ) 2014, 8:571-579.
Yoon KC, You IC, Im SK, Jeong TS, Park YG, Choi J: Application of umbilical cord serum eyedrops for the treatment of neurotrophic keratitis. Ophthalmology 2007, 114(9):1637-1642.
Petroutsos G, Guimaraes R, Giraud JP, Pouliquen Y: Corticosteroids and corneal epithelial wound healing. The British journal of ophthalmology 1982, 66(11):705-708.
Aifa A, Gueudry J, Portmann A, Delcampe A, Muraine M: Topical treatment with a new matrix therapy agent (RGTA) for the treatment of corneal neurotrophic ulcers. Investigative ophthalmology & visual science 2012, 53(13):8181-8185.
Davis EA, Dohlman CH: Neurotrophic keratitis. International ophthalmology clinics 2001, 41(1):1-11.
Reynolds SA, Kabat AG: Therapeutic options for the management of early neurotrophic keratopathy: a case report and review. Optometry (St Louis, Mo) 2006, 77(10):503-507.
Schornack MM, Pyle J, Patel SV: Scleral lenses in the management of ocular surface disease. Ophthalmology 2014, 121(7):1398-1405.
Chen HJ, Pires RT, Tseng SC: Amniotic membrane transplantation for severe neurotrophic corneal ulcers. The British journal of ophthalmology 2000, 84(8):826-833.
Diaz-Valle D, Benitez del Castillo Sanchez JM, Diaz Rodriguez E, Toledano Fernandez N, Arteaga Sanchez A, Sayagues Gomez O: [Neurotrophic keratopathy management with cyanoacrylate tarsorraphy and autologous serum]. Archivos de la Sociedad Espanola de Oftalmologia 2003, 78(2):119- 122.
Hanada K, Igarashi S, Muramatsu O, Yoshida A: Therapeutic keratoplasty for corneal perforation: clinical results and complications. Cornea 2008, 27(2):156-160.
Reed JW, Joyner SJ, Knauer WJ, 3rd: Penetrating keratoplasty for herpes zoster keratopathy. American journal of ophthalmology 1989, 107(3):257- 261.
Pavan-Langston D, Dohlman CH: Boston keratoprosthesis treatment of herpes zoster neurotrophic keratopathy. Ophthalmology 2008, 115(2 Suppl):S21-23.
Liu T, Tang Q, Hendricks RL: Inflammatory infiltration of the trigeminal ganglion after herpes simplex virus type 1 corneal infection. Journal of virology 1996, 70(1):264-271.
Shimomura Y: [Herpes simplex virus latency, reactivation, and a new antiviral therapy for herpetic keratitis]. Nippon Ganka Gakkai zasshi 2008, 112(3):247-264; discussion 265.
Predictors of recurrent herpes simplex virus keratitis. Herpetic Eye Disease Study Group. Cornea 2001, 20(2):123-128.
A controlled trial of oral acyclovir for the prevention of stromal keratitis or iritis in patients with herpes simplex virus epithelial keratitis. The Epithelial Keratitis Trial. The Herpetic Eye Disease Study Group. Archives of ophthalmology (Chicago, Ill: 1960) 1997, 115(6):703-712.
Acyclovir for the prevention of recurrent herpes simplex virus eye disease. Herpetic Eye Disease Study Group. The New England journal of medicine 1998, 339(5):300-306.
Bhatt UK, Abdul Karim MN, Prydal JI, Maharajan SV, Fares U: Oral antivirals for preventing recurrent herpes simplex keratitis in people with corneal grafts. The Cochrane database of systematic reviews 2016, 11:Cd007824.
